Stada Arzneimittel AG - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Stada Arzneimittel AG. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Stada Arzneimittel AG(STADA). The Group's principal activity is to manufacture generic drugs. The Group operates through two core segments: Generics and Branded products. Through Generics segment, the Group offers medicines after the expiration of their patents at the same quality but for significantly lower prices. Through Branded Products segment, the Group focuses on multisource products with off-patent active ingredients. The Group's current branded products portfolio includes primarily non-prescription which are called over-the-counter products (OTC products), and in some national markets also prescription drugs. The non-core segment includes commercial business. The Group mainly operates in Europe, America and Asia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report